Dr. Ranjita Shegokar
Free University of Berlin, Germany
Email: ranjita@arcsindia.com
Qualifications
2010 Ph.D., SNDT University, India
2003 M.Sc., SNDT University, India
2001 B.Sc., BAMU University, India
Publications (selected)
-
Shegokar R., et al., Carotenoid
lutein: a promising candidate for Pharmaceutical, nutraceutical and
cosmeceutical application, Journal of Dietary supplements, 2012, 9(3):183-210.
-
Shegokar R., et al., Preparation,
characterization of cell base delivery of surface modified stavudine lipid
nanoparticles, Journal of Nanomedicine and Biotherapeutic Discovery, 2012, 1:
192. doi:10.4172/scientificreports.192.
-
Doktorovova S., Shegokar R., et al.,
Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic
solid lipid nanoparticles (cSLN), European Journal of Pharmaceutical Sciences,
2012 Apr 11;45(5):606-12.
-
Kakran M., Shegokar R., et al.,
Fabrication of quercetin nanocrystals: comparison of different methods,
European Journal of Pharmaceutics and Biopharmaceutics, 2012, 80 (1), 113-21.
-
Shegokar R., et al., Surface modified
nevirapine nanosuspension for HIV viral reservoir targeting: in vitro and in
vivo evaluation, International Journal of Pharmaceutics, 2011, 421(2):341-52.
-
Shegokar R., et al., Nevirapine
nanosuspension: comparative investigation of production methods, Nanotechnology
Development, 2011, 1:e4: 16-22.
-
Doktorovova S., Shegokar R., et al.,
Cationic solid lipid nanoparticles (cSLN) –structure, stability and DNA binding
capacity correlation, International Journal of Pharmaceutics, 2011, 420 (2),
341-349.
-
Mitri K., Shegokar R., et al., Lutein
nanocrystals as antioxidant formulation for oral and dermal delivery,
International Journal of Pharmaceutics, 2011, 420 (1), 141-146.
-
Al Shaal L., Shegokar R., et al.,
Production and characterization of antioxidant apigenin nanocrystals as a novel
UV skin protective formulation, International Journal of Pharmaceutics, 2011,
420 (1), 133-140.
-
Mitri K., Shegokar R., et al., Lipid
nanocarriers for dermal delivery of lutein: preparation, characterization,
stability and performances, International Journal of Pharmaceutics, 2011, 414
(1-2), 267-275.
-
Shegokar R., et al., Present status of
nanoparticle research for treatment of tuberculosis, Journal of Pharmacy &
Pharmaceutical Sciences, 2011, 14 (1), 100-116.
-
Shegokar R., et al., Development of
nevirapine nanosuspensions for HIV chemotherapy, Die Pharmazie, 2011, 66 (6),
408-15.Shegokar R., et al., Delivery of SiRNA: role of carrier systems, Die
Pharmazie, 2011, 66 (5), 313-318.
-
Shegokar R., et al., Stavudine entrapped
lipid nanoparticles for targeting lymphatic HIV reservoirs, Die Pharmazie,
2011, 66 (4), 264-271.
-
Shegokar R., et al., Production &
stability of stavudine solid lipid nanoparticles - from lab to industrial
scale, International Journal of Pharmaceutics, 2011, 416 (2), 461-470.
-
Shegokar R., et al., In vitro protein
adsorption studies on nevirapine nanosuspensions for HIV chemotherapy,
Nanomedicine: Nanotechnology, Biology, and Medicine, 2011, 7, 333–340.Al Shaal
L., Müller R. H., Shegokar R., Apigenin nanosuspensions: lab scale to pilot
scale, Die Pharmazie, 2010, 65 (12), 877-884.
-
Shegokar R., et al., NanoCrystals:
industrially feasible multifunctional formulation technology for poorly soluble
actives, International Journal of Pharmaceutics, 2010, 399 (1-2), 129-139.